Hepatocellular carcinoma: Clinical trials to watch.
Ongoing trials for hepatocellular carcinoma (HCC) screening and treatment have the potential to transform management.
APA
Hsiehchen D, Singal AG (2026). Hepatocellular carcinoma: Clinical trials to watch.. Med (New York, N.Y.), 7(3), 101038. https://doi.org/10.1016/j.medj.2026.101038
MLA
Hsiehchen D, et al.. "Hepatocellular carcinoma: Clinical trials to watch.." Med (New York, N.Y.), vol. 7, no. 3, 2026, pp. 101038.
PMID
41831431
Abstract
Ongoing trials for hepatocellular carcinoma (HCC) screening and treatment have the potential to transform management. Screening trials are comparing novel imaging and blood-based strategies versus abdominal ultrasound for early HCC detection. Immune checkpoint inhibitors have transformed the therapeutic landscape, with trials evaluating potential benefit in early-stage or intermediate-stage HCC as well as new regimens to improve survival for advanced-stage HCC.
MeSH Terms
Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Immune Checkpoint Inhibitors; Clinical Trials as Topic; Early Detection of Cancer; Neoplasm Staging